SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-23-021175
Filing Date
2023-02-14
Accepted
2023-02-14 12:12:22
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm236365d1_sc13ga.htm SC 13G/A 39908
  Complete submission text file 0001104659-23-021175.txt   41452
Mailing Address 51 CHARLES LINDBERGH BOULEVARD UNIONDALE NY 11553
Business Address 51 CHARLES LINDBERGH BOULEVARD UNIONDALE NY 11553 (415) 655-4899
Angion Biomedica Corp. (Subject) CIK: 0001601485 (see all company filings)

IRS No.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-93548 | Film No.: 23625344
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ANGION BIOMEDICA CORP. 51 CHARLES LINDBERGH BOULEVARD UNIONDALE NY 11553
Business Address C/O ANGION BIOMEDICA CORP. 51 CHARLES LINDBERGH BOULEVARD UNIONDALE NY 11553 415-655-4899
EISA-ABC LLC (Filed by) CIK: 0001878914 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A